Loading...

enVVeno Medical Corporation

HJLINASDAQ
Healthcare
Medical - Devices
$10.38
$-0.21(-1.98%)

enVVeno Medical Corporation (HJLI) Stock Competitors & Peer Comparison

See (HJLI) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
HJLI$10.38-1.98%98.3MN/AN/AN/A
ABT$131.02-0.26%228B16.44$7.97+1.78%
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
BSX$102.64-0.10%152B60.72$1.69N/A
SYK$376.61-0.02%144B49.87$7.55+0.88%
MDT$92.08-0.71%118B25.50$3.61+3.06%
EW$76.93-1.57%45.2B32.18$2.39N/A
DXCM$80.17+2.98%31.4B56.46$1.42N/A
PHG$26.99+1.16%25.7B142.03$0.19+3.29%
STE$243.76+0.89%24B37.33$6.53+0.94%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

HJLI vs ABT Comparison August 2025

HJLI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HJLI stands at 98.3M. In comparison, ABT has a market cap of 228B. Regarding current trading prices, HJLI is priced at $10.38, while ABT trades at $131.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HJLI currently has a P/E ratio of N/A, whereas ABT's P/E ratio is 16.44. In terms of profitability, HJLI's ROE is -0.00%, compared to ABT's ROE of +0.32%. Regarding short-term risk, HJLI is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for HJLI.Check ABT's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;